The recurrent presence of JAK2, especially in the hepatitis B and influenza A pathways, highlights its pivotal role and positions it as a key target for future molecular docking studies aimed at exploring the molecular interactions between A. annua compounds and this protein. The gene discussed is JAK2; the disease is hepatitis B virus infection.